A Study to Learn How Safe BAY2666605 is, How it Affects the Body, How it Moves Into, Through and Out of the Body, the Maximum Amount That Can be Given and Its Action Against Tumors in Adult Participants With Skin Cancer That Has Spread to Other Parts of the Body and Other Types of Advanced Cancer

Clinical trial NCT04809805 · TERMINATED

Trial details

NCT number: NCT04809805
Sponsor: Bayer
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Metastatic Melanoma and Other Solid Tumors

Start date: 2021-04-15
Primary completion: 2022-11-09
Enrollment: 5

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.